Recruiting

ACCESS

Sponsor:

Care Partners

Code:

NCT04049188

Conditions

Cancer Metastatic

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Single-Fraction Palliative Radiation Therapy

Study Details

Brief summary:

Feasibility study to report on the impact of ACCESS of single-fraction radiation therapy on cancer patients with bone metastases enrolled in hospice care.

Conditions

Cancer Metastatic

Study ID

NCT04049188

Start date

Jan 1, 2020

Status verified date

Jan, 2020

Completion date

Dec 31, 2021

Anticipated

Primary completion date

Jan 1, 2021

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Solid Tumor Malignancies and Multiple Myeloma with Bone Metastases and Associated Bone Pain Enrolled in Hospice

Exclusion Criteria:

  • Decisionally-Impaired Subjects, Pregnant Women

Study Design

Enrollment

31 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Single-Fraction Palliative RT

Single-Fraction Palliative Radiation Therapy Adminstration

Interventions

Single-Fraction Palliative Radiation Therapy

All subjects will be undergo single-fraction palliative radiation therapy who have cancer and associated bone metastases and symptomatic bone pain.

Primary outcome measure

  • Change in Opioid Use for Pain Management [ Time Frame: Through study completion, an average of 1 year ]

Central Contacts and Locations

Locations

CarePartners

Recruiting

Hillsboro, Oregon, United States, 97006

Contacts

Christa Nicholas

503-648-9565

Principal Investigator:

Andy Kyler, BSN, MBA

More Information

Sponsor

Care Partners

Last update posted

Jan 23, 2020

Last verified

Jan, 2020

Keywords

  • Cancer Patients Hospice Care
  • Palliative Radiation Therapy

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Care Partners on 2020-01-23.